Searched for
ASTRAZENECA PHARMA SHARE PRICE
Nifty heading to 25,000, Bank Nifty to 60,000 soon; prefer private banks, NBFCs over PSU banks: CA Rudramurthy BVIndian equity markets are showing strong upward momentum, breaking past key resistance levels. Analysts believe this rally has significant ...- These large- and mid-cap stocks can give more than 20% return in 1 year, according to analystsIn just a few days, the Q1 earnings season for FY27 will start. But before that will come the season of business updates. And that needs to...
- Vedanta Power, Iron & Steel and Oil & Gas shares crash up to 8%. What’s triggering the selloff?Vedanta shares saw profit-taking after a strong rally in newly demerged entities, with most segments falling up to 8% over 14 sessions. Ved...
- Weekly Top Picks: These stocks scored 10 on 10 on Stock Reports PlusStock Reports Plus, powered by Refinitiv, undertakes detailed company analysis for 4,000+ listed stocks. In addition to detailed company an...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsGiven the state of the market these days, it would be wise to be selective. Not only in terms of stocks, but also in terms of sectors. For ...
- Medical device maker Zimmer Biomet to hire 500 employees in 3 years for tech centre in IndiaMedical device giant Zimmer Biomet is set to significantly expand its Indian footprint by hiring 500 professionals over three years for its...
- Two Trades for Today: An auto sector major for a 6.25% upmove, a mid-cap pharma stock for a gain of almost 7%Our technical analysts identify select stocks every trading day that may gain momentum even in volatile markets. Here are the technical cal...
- These 7 private and public banking stocks have an upside of up to 24% in one year, according to analystsAt the end of the day, both private and PSU banks are equally impacted by what goes on in the economy. If they are behaving differently in ...
- Telangana plans drug discovery push to move Hyderabad up pharma value chainTelangana is charting a new course to elevate Hyderabad into a global drug discovery hub. The state is fostering an integrated ecosystem by...
- For investors looking beyond the short-term horizon: 5 mid-cap stocks from different sectors with upside potential up to 28%All is once again quiet on the US-Iran war front, and some kind of dialogue to resolve the issues between the two seems to be still underwa...
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 24%Any long-term investor knows that corrections are part of every bull run. But it is important that they be aware whether the correction is ...
- Ahead of Market: 10 things that will decide stock market action on TuesdayIndian equities ended lower, snapping a two-day rally as escalating Iran-US tensions and profit booking weighed on sentiment. Sensex fell 3...
- Weekly Top Picks: These stocks scored 10 on 10 on Stock Reports PlusStock Reports Plus, powered by Refinitiv, undertakes detailed company analysis for 4,000+ listed stocks. In addition to detailed company an...
- Should they now be part of a long-term investing framework? 7 healthcare stocks with upside potential of up to 25%India’s healthcare market may grow steadily, but hospital chains can grow faster as formalisation continues. Healthcare is all about market...
- Top Nifty50 stocks analysts suggest buying in this volatile weekStock Reports Plus, powered by Refinitiv, is a comprehensive report that evaluates five key components of 4,000+ listed stocks – earnings, ...
- Stocks in news: Waaree Energies, Kotak Bank, HDFC Bank, Strides Pharma, Persistent SystemsIndian markets showed volatility, ending nearly flat despite positive signals. Analysts note Nifty faces resistance from key moving average...
- For investors with ability – and patience to wait 3 years, not 3 months: 6 large-cap stocks with upside potential of up to 33%The interesting point about the large-cap space today is not that prices have collapsed. In most cases, they have not. The more important c...
- Scanning cancer, up close & personal: A revolution is underway in cancer diagnosisA gene-based test called next-generation sequencing can identify precise mutations, which can then be treated with targeted therapies. Sinc...
- Global drugmakers rush to boost US presence as tariff threat loomsGlobal drug companies are boosting U.S. production and stockpiling medicines. This is a response to potential tariffs on branded drugs. Com...
- AstraZeneca's Enhertu gets regulatory approval in India for first-line HER2-positive breast cancerAstraZeneca Pharma India has secured approval from India's drug regulator for its smart chemotherapy drug Enhertu. This allows for its impo...
Load More
